HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (27) Citing Articles via Google Scholar Google Scholar Articles by Pisupati, J. Articles by Venkataramanan, R. Search for Related Content PubMed PubMed Citation Articles by Pisupati, J. Articles by Venkataramanan, R.

Intraindividual and Interindividual Variations in the Pharmacokinetics of Mycophenolic Acid in Liver Transplant Patients

From the Department of Pharmaceutical Sciences and Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania (Dr Pisupati, Dr Burckart, Ms Zuckerman, Dr Venkataramanan) and the Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Jain, Dr Hamad, Dr Fung).

The authors evaluated the intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid after oral administration of mycophenolate mofetil in 10 liver transplant patients. Mycophenolic acid and its metabolite, mycophenolic acid glucuronide, were measured in plasma and urine by high-pressure liquid chromatography. The plasma protein binding of mycophenolic acid was determined by ultrafiltration. The maximum concentration of mycophenolic acid in plasma increased significantly (P .05) with time from 9.1 ± 7.2 µg/mL (<1 week) to 36.7 ± 15.6 µg/mL (1 month). The area under the plasma concentration versus time curve of mycophenolic acid also increased significantly with time, from 50.8 ± 42.1 µg•h/mL to 118.0 ± 57.6 µg•h/mL (P .05). The plasma protein binding of mycophenolic acid increased from 92% to 98%, and the apparent oral clearance [CL/F] decreased from 32.9 ± 21.4 L/h during the first study period to 9.0 ± 4.4 L/h (P .05) during the third study period. The apparent intrinsic clearance of mycophenolic acid did not change significantly over time. The ratio of the area under the curve of mycophenolic acid glucluronide to mycophenolic acid in plasma decreased with time (25.5 ± 21.2 vs 8.0 ± 3.3) but did not reach statistical significance. The increased binding of mycophenolic acid to plasma proteins with time after transplantation appeared to contribute to the intraindividual variation, whereas differences in the ability of the liver to metabolize mycophenolic acid between patients appear to contribute to the large interindividual variation in the pharmacokinetics of mycophenolic acid. The observations in this study support the concept of measuring the unbound concentration of mycophenolic acid to optimize immunosuppressive drug therapy with mycophenolic acid.

Key Words: Mycophenolic acid • mycophenolate mofetil • immunosuppressive drugs • pharmacokinetics • mycophenolic acid glucuronide • interindividual variations • intraindividual variations

Address for reprints: Raman Venkataramanan, PhD, FCP, 718 Salk Hall, University of Pittsburgh, Pittsburgh, PA 15261.

This article has been cited by other articles:

				A. Jain, R. Venkataramanan, R. Sharma, T. Kwong, P. Abt, M. Orloff, R. Kashyap, G. Tsoulfas, and A. Bozorgzadeh Pharmacokinetics of Mycophenolic Acid in Live Donor Liver Transplant Patients vs Deceased Donor Liver Transplant Patients J. Clin. Pharmacol., May 1, 2008; 48(5): 547 - 552. [Abstract] [Full Text] [PDF]

				L. S. Ting, N. Partovi, R. D Levy, K W. Riggs, and M. H. Ensom Pharmacokinetics of Mycophenolic Acid and Its Glucuronidated Metabolites in Stable Lung Transplant Recipients Ann. Pharmacother., September 1, 2006; 40(9): 1509 - 1515. [Abstract] [Full Text] [PDF]